Reuters – 3SBio to Go Private in $340M Deal

Chinese biotechnology firm 3SBio Inc. said it agreed to be bought by Decade Sunshine Ltd. for about $340 million, Reuters reported. The offer of $15.40 per American Depositary Shares is at a premium of about 12 percent to the ADS’s Thursday close of $13.79.

(Reuters) – Chinese biotechnology firm 3SBio Inc said it agreed to be bought by Decade Sunshine Ltd for about $340 million.

The offer of $15.40 per American Depositary Shares (ADS) is at a premium of about 12 percent to the ADS’s Thursday close of $13.79.

3SBio Chief Executive Jing Lou had offered to take the company private for up to $15 per ADS, or about $331 million, last September.

Related Posts

Leave a Reply

PEHUB Community

Join the 12494 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

Look Who’s Tweeting

Reuters VC and PE feed

RSS Feed Widget

Groups